| Previous Close | 119.040 |
| Open | 119.170 |
| Bid | 119.450 x 400 |
| Ask | 119.490 x 100 |
| Day's Range | 118.840 - 120.000 |
| 52 Week Range | 81.120 - 121.750 |
| Volume | 794,524 |
| Avg. Volume | 1,341,020 |
| Market Cap | 25.03B |
| Beta | 0.84 |
| PE Ratio (TTM) | 39.67 |
| EPS (TTM) | 3.01 |
| Earnings Date | Jul 26, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 123.86 |
- TheStreet.com•9 hours ago
Edwards Lifesciences: Cramer's Top Takeaways
Mike Mussallem, chairman and CEO of Edwards Lifesciences, tells Jim Cramer about his company's heart-valve advancements.
- CNBC•21 hours ago
Cramer Remix: Snap is the No. 1 reason to own Facebook
Jim Cramer broke down his strategy to why Snap fell out of his favor.
Zacks•yesterdayEdwards Lifesciences (EW) Q2 Earnings: A Surprise in Store?
Edwards Lifesciences (EW) will likely ride high in Q2 earnings banking on continued growth in its highly advanced Transcatheter Heart Valve space.
